ArticleBMJ open2019

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.

Emmanuel Cognat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.